Mariaelisa Graff
Assistant Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
While the earliest pathological signs of cardiovascular disease (CVD) emerge before age 20, current adult-based risk thresholds fail to identify a substantial fraction of high-risk children. With the rising prevalence of childhood obesity, the need for early and sensitive detection of cardiovascular-kidney-metabolic disease (CKMD) risk is paramount to enable timely intervention that can prevent the trajectory toward CVD in later life. To identify early accessible molecular biomarkers of CKMD in children, we measured 25 CKMD phenotypes, spanning liver, adipose, vascular, and dysglycemia traits, linked those to the circulating proteome and built a multi-protein signature of composite CKMD, leveraging data from 273 children and adolescents (13.1 ± 2.7 years; 53% females). We compared these results to the adult CKMD proteome, using data from 685 adults from the same community and 28,257 adults from the UK Biobank. The pediatric CKMD proteome was highly concordant with the adult CKMD proteome, reflecting known and novel mechanisms of pancreatic beta-cell health and insulin sensitivity, liver homeostasis, inflammation, and cholesterol metabolism. Similarly, multi-protein signatures of composite CKMD phenotypes in children were strongly associated with CKMD-related outcomes in both adult populations. Importantly, many proteins linked to pediatric CKMD were modifiable with GLP-1 receptor agonist therapy, associated with adult CKMD-related outcomes in a large-scale proteome-wide association study (PWAS), and exhibited significant variability during development (ages 4-24 years). These findings demonstrate that CKMD develops starting early in life-course continuum, with proteomic profiles linked to future irreversible CVD conditions emerging early in life when they may still be reversible. This highlights a critical opportunity to improve CVD-free longevity through precision medicine diagnosis and intervention in children and adolescents.
Year:
2025
Background Severe obesity (SevO; BMI ≥40 kg/m²) is rapidly increasing globally and disproportionately affects minority populations. However, it remains understudied in mechanistic and omics literature. Lipid metabolism plays a central role in obesity-related cardiometabolic disease (CMD), but the relationship between molecular lipid species and SevO is poorly understood, particularly in high-risk groups. Methods We analyzed 578 participants from the Cameron County Hispanic Cohort (CCHC) with fasting plasma lipidomic and genetic data, comparing those living with SevO (n=185) to non-obese controls (n=393). A total of 830 circulating lipid species across 49 classes were quantified. Associations between individual lipids and SevO were assessed using logistic regression and orthogonal projections to latent structures discriminant analysis (OPLS-DA). Potential causal links were assessed using network deconvolution mendelian randomization (NDMR), and influential lipids were correlated with CMD traits and DXA-derived body composition. Results Participants with SevO exhibited statistically significantly more adverse cardiometabolic risk factors than controls. Lipidomic profiling revealed broad alterations: shorter, saturated, and monounsaturated triacylglycerols were markedly elevated, while lysophospholipids, plasmalogens, cholesteryl esters, and long-chain lipids were reduced in individuals with SevO when compared to controls (BMI ≥ 18.5 and > 25 kg/m²). OPLS-DA identified over 300 influential lipid species predictive of SevO status. NDMR analyses implicated specific triacylglycerol species as potentially causally linked with SevO status. Influential lipids correlated with insulin resistance, liver steatosis, body fat measures, and HDL-C (absolute value ranges 0.2-0.4). Conclusions Our findings reveal that SevO is marked by extensive and lipid class-specific dysregulation of the circulating lipidome, with strong links to cardiometabolic risk. Notably, triacylglycerols containing shorter length acyl chains emerged as a distinctive lipid signature of SevO—consistently elevated, strongly discriminative of SevO status, and uniquely exhibiting a consistent causal relationship. Our results provide compelling evidence for a novel lipidomic pathway underpinning severe obesity and underscore critical avenues for future research into its genetic, dietary, and mechanistic determinants.
Year:
2025
Background Many present analyses of Hispanic/Latino populations in epidemiologic research aggregate all members of this ethnic group, despite immense diversity in genetic backgrounds, environment, and culture between and across Hispanic/Latino background groups. Using the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), we examined the role of self-identified background group and genetic ancestry proportions in gene-environment interactions influencing the relationship between body mass index (BMI) and a polygenic score for BMI (PGS BMI ). Methods Weighted univariate and multivariable generalized linear models were executed to compare the effects of environmental variables identified a priori by McArdle et al. 2021. Both Amerindigenous (AME) ancestry proportion and background group identity were statistically modeled as confounders both through stratified and joint analyses to understand their influence on the relationship between BMI and PGS BMI , while incorporating gene-environment interactions of PGS x diet and PGS x age-at-immigration. Results After complex survey weighting, 7,075 participants remained in the analytic sample, representing individuals of six background groups: Central American, Cuban, Dominican, Mexican, Puerto Rican, and South American. The distributions of key environmental and sociocultural variables were heterogeneous between Hispanic/Latino background groups. Associations of these variables with AME ancestry were similarly heterogeneous upon stratification, indicating confounding by background group. In a predictive model for BMI incorporating health, immigration, and environmental variables, PGS BMI performance decreased with increasing AME ancestry proportion. In this model, most statistically significant GxE interactions lost significance after ancestry and background stratification, except for PGS x age-at-immigration interactions in some strata: Mexican background individuals born in the US compared to those >=21 years old at migration (β=1.33, p =21 years old at migration (β=4.38, p =21 years old at migration (β=2.20, p=0.015), where US-born includes individuals born in the US 50 states/DC. Conclusions Controlling for self-identified background group identity and genetic ancestry did not eliminate statistically significant differences in interactions between AME ancestry and environmental variables in certain strata of AME ancestry among some Hispanic/Latino background groups in HCHS/SOL.
Year:
2024
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.
Year:
2024
Genome-wide association studies (GWAS) have identified numerous body mass index (BMI) loci. However, most underlying mechanisms from risk locus to BMI remain unknown. Leveraging omics data through integrative analyses could provide more comprehensive views of biological pathways on BMI. We analyzed genotype and blood gene expression data in up to 5,619 samples from the Framingham Heart Study (FHS). Using 3,992 single nucleotide polymorphisms (SNPs) at 97 BMI loci and 20,692 transcripts within 1 Mb, we performed separate association analyses of transcript with BMI and SNP with transcript (P BMI and P SNP , respectively) and then a correlated meta-analysis between the full summary data sets (P META ). We identified transcripts that met Bonferroni-corrected significance for each omic, were more significant in the correlated meta-analysis than each omic, and were at least nominally associated with BMI in FHS data. Among 308 significant SNP-transcript-BMI associations, we identified seven genes ( NT5C2 , GSTM3 , SNAPC3 , SPNS1 , TMEM245 , YPEL3 , and ZNF646 ) in five association regions. Using an independent sample of blood gene expression data, we validated results for SNAPC3 and YPEL3 . We tested for generalization of these associations in hypothalamus, nucleus accumbens, and liver and observed significant (P META <0.05 & P META <P SNP & P META <P BMI ) results for YPEL3 in nucleus accumbens and NT5C2 , SNAPC3 , TMEM245 , YPEL3 , and ZNF646 in liver. The identified genes help link the genetic variation at obesity risk loci to biological mechanisms and health outcomes, thus translating GWAS findings to function.
Year:
2024
Collaborators (64)
Xiaofeng Zhu
Professor
Case Western Reserve University
Krista Perreira
Professor
University of North Carolina at Chapel Hill School of Medicine
Harold Snieder
Scientific Staff
University Medical Center Groningen
Amy Bentley
National Human Genome Research Institute
Cristina Menni
King’s College London
Nicholas Wareham
Director
University of Cambridge
Joseph McCormick
James H. Steele Professor
-
Honghuang Lin
Professor
UMass Medical School
Gregory A. Talavera
San Diego State University
Lindsay Fernandez-Rhodes
Associate Professor
Pennsylvania State University
Andrew S. Perry
Vanderbilt University Medical Center
Linda C. Gallo
Professor
San Diego State University
Shilin Zhao
Vanderbilt University Medical Center
Vilmundur Gudnason
Professor
University of Iceland
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Jennifer Ann Smith
Professor
University of Michigan
Miryoung Lee
Associate Professor
The University of Texas Health Science Center at Houston
Sarah Harris
University of Edinburgh
Mohammad Yaser Anwar
Tenure-track Assistant Professor
The University of Texas Health Science Center at Houston
Ching-Ti Liu
Boston University
Ko Willems van Dijk
Professor
Leiden University Medical Center
massimo mangino
Honorary Senior Lecturer
King’s College London
John Blangero
Professor/Director Genomics Computing Center
University of Texas Rio Grande Valley School of Medicine
Heming Wang
Assistant Professor
Brigham and Women's Hospital
Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
University Medical Center Groningen
Heather M Highland
University of North Carolina at Chapel Hill
Marcus Dörr
University Medicine Greifswald
Paul de Vries
Assistant Professor
The University of Texas Health Science Center at Houston School of Public Health
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Quinn Wells
Associate Professor of Medicine
Vanderbilt University Medical Center
Eric Farber-Eger
Vanderbilt University Medical Center
Iris M. Heid
University of Regensburg
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Myriam Fornage
-
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Mary Feitosa
Associate Professor
Washington University School of Medicine
Debbie A Lawlor
Academic , Professor of Epidemiology, MRC Investigator and BHF Chair
University of Bristol
Sami Heikkinen
Research Director
University of Eastern Finland
Peter Y Liu
University of California
Tanika Kelly
Professor
University of Chicago
Kari North
Professor
University of North Carolina at Chapel Hill
Christina Cordero
Research Associate Professor
University of Miami
Eric Gamazon
University of Chicago
Kisung Nam
Seoul National University
Michael Province
Professor, Head Division of Statistical Genomics
Washington University in St. Louis
Carmen R Isasi
Albert Einstein College of Medicine
Joanne Curran
Professor
The University of Texas Rio Grande Valley
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Quan Sun
Research Assistant Professor
University of Pennsylvania
Gutierrez Absalon
Assistant Professor of Medicine
The University of Texas Health Science Center at Houston
John Attia
University of Newcastle Australia
Nicholette Allred
Wake Forest Baptist Medical Center
Daeeun Kim
Research Professor
Seoul National University Hospital
Brian Cade
Investigator
Brigham and Women's Hospital
Anne Justice
Associate Professor
Geisinger Health
Terho Lehtimäki
University of Tampere
SINA A. GHARIB
University of Washington
Peter Meikle
Head
Baker Heart and Diabetes Institute
Jian'an Luan
University of Cambridge
Matthew Nayor
Boston University School of Medicine
Quanhu Sheng
Associate Professor
Vanderbilt University Medical Center
Karen L. Mohlke
Professor
University of North Carolina at Chapel Hill
Penny Gordon-Larsen
Vice Chancellor for Research and William R. Kenan, Jr. Distinguished Professor, Nutrition
University of North Carolina at Chapel Hill
Corey Giles
Laboratory Head
Baker Heart and Diabetes Institute
Make your next move.
Prepare your application
Review drafts before you send them.